Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-017626

Pres and CEO bought 6,500 shares at $7.74 ($50,278)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manion Douglas J. Pres and CEO 2023-03-09 Purchase +6,500 $7.74 $50,278 6,500 D
Open-market purchases · 6,500 sh · avg $7.74 · $50,278
Loading xslF345X03/doc4.xml…